Price to Book Value Chart

View Price to Book Value for IMTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
September 18, 2026 2.579
September 17, 2026 2.639
September 16, 2026 2.585
September 15, 2026 2.573
September 14, 2026 2.579
September 11, 2026 2.630
September 10, 2026 2.618
September 09, 2026 2.726
September 08, 2026 2.824
September 04, 2026 2.860
September 03, 2026 2.830
September 02, 2026 2.842
September 01, 2026 2.821
August 31, 2026 2.851
August 28, 2026 2.827
August 27, 2026 2.800
August 26, 2026 2.821
August 25, 2026 2.764
August 24, 2026 2.600
August 21, 2026 2.672
August 20, 2026 2.558
August 19, 2026 2.767
August 18, 2026 2.720
August 17, 2026 2.767
August 14, 2026 2.824
Date Value
August 13, 2026 2.869
August 12, 2026 2.905
August 11, 2026 2.917
August 10, 2026 2.908
August 07, 2026 2.887
August 06, 2026 2.818
August 05, 2026 2.923
August 04, 2026 2.806
August 03, 2026 2.698
July 31, 2026 2.591
July 30, 2026 2.752
July 29, 2026 2.690
July 28, 2026 2.613
July 27, 2026 2.582
July 24, 2026 2.716
July 23, 2026 2.779
July 22, 2026 2.743
July 21, 2026 2.815
July 20, 2026 2.761
July 17, 2026 2.869
July 16, 2026 2.812
July 15, 2026 2.833
July 14, 2026 2.797
July 13, 2026 2.761
July 10, 2026 2.896

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
MediGene AG --
InflaRx NV 1.843
BioNTech SE 1.189
Moderna, Inc. 9.091
Intellia Therapeutics, Inc. 2.336

Price to Book Value Related Metrics

PS Ratio 23.01
PEG Ratio -0.0261
Price 8.62
Earnings Yield -21.45%
Market Cap 1.178B
PEGY Ratio -0.0261